Search Results for: Majority of Oncology Clinical Trials
Articles
October 21, 2013
Regeneron & Sanofi Report Positive Top-Line Results October 21, 2013
Sanofi and Regeneron Pharmaceuticals, Inc. recently announced that the Phase III ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody...
August 27, 2013
Pfizer’s Lung Cancer Drug Rejected; Deemed Too Costly August 27, 2013
Pfizer Ltd has expressed concern and disappointment that the final appraisal determination (FAD) from the National Institute of Health and...
November 26, 2012
11/28/2012 November 26, 2012
CoreRx & ViroPro Announce Agreement CoreRx, Inc. and Viropro, Inc. recently announced the two companies have entered into a Reciprocal...
November 8, 2012
11/14/2012 November 8, 2012
A Note to The Pharmaceutical Industry Upon The Re-Election of Barack Obama By: Matthew Herper, Forbes Staff, mherper@forbes.com I've covered...
October 25, 2012
10/30/2012 October 25, 2012
Arthritis Signifies a Vast Untouched Market, Finds Frost & Sullivan Tumor necrosis factor (TNF) inhibitors are currently the only therapeutic...
May 6, 2012
5/9/2012 May 6, 2012
Caisson Biotech Enters Potential $100 Million Agreement Caisson Biotech, L.L.C. recently announced it has entered into a development and license...
February 12, 2012
2/14/2012 February 12, 2012
Bend Research Signs License Agreement With Eli Lilly & Company Bend Research Inc., a leading independent drug formulation development and...
January 22, 2012
1/24/2012 January 22, 2012
Dishman Pharmaceuticals & Chemicals Acquires Creapharm Parenterals Switzerland-based Carbogen Amcis AG, a leading pharmaceutical process development and API manufacturing company,...
November 27, 2011
11/29/2011 November 27, 2011
Biocon Launches Haselmeier's Insulin Pen in India Haselmeier recently announced that Biocon, one of Asia's premier biotechnology companies, has launched...
